Lactose
- Generic Name
- Lactose
- Drug Type
- Small Molecule
- Chemical Formula
- C12H22O11
- CAS Number
- 63-42-3
- Unique Ingredient Identifier
- 3SY5LH9PMK
- Background
A disaccharide of glucose and galactose in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.
- Indication
Not Available
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Hypothyroidism, Opioid Dependence, Thyroid Cancer
- Associated Therapies
- Maintenance treatment, opioids, Opioid Detoxification
The Effects of N-acetylcysteine on Performance and Redox Homeostasis
- Conditions
- Glutathione Metabolism Anemias
- Interventions
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Aristotle University Of Thessaloniki
- Target Recruit Count
- 36
- Registration Number
- NCT03121222
- Locations
- 🇨🇾
European University Cyprus, Nicosia, Cyprus
🇬🇷National and Kapodistrian University of Athens, Athens, Greece
🇬🇷Aristotle University of Thessaloniki, Thessaloniki, Greece
Pain and Magnesium
- Conditions
- Neuropathic Pain Induced by Mastectomy
- First Posted Date
- 2017-02-24
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Target Recruit Count
- 100
- Registration Number
- NCT03063931
- Locations
- 🇫🇷
CHU Clermont-Ferrand, Clermont-Ferrand, France
Lithium for Fracture Treatment: a Double Blind Randomized Controlled Trial (LiFT)
- First Posted Date
- 2016-12-21
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Sunnybrook Health Sciences Centre
- Target Recruit Count
- 160
- Registration Number
- NCT02999022
- Locations
- 🇨🇦
The Ottawa Hospital Civic Campus, Ottawa, Ontario, Canada
🇨🇦Royal Victoria Regional Health Centre, Barrie, Ontario, Canada
🇨🇦Hamilton Health Sciences, Hamilton, Ontario, Canada
Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- Mashhad University of Medical Sciences
- Target Recruit Count
- 69
- Registration Number
- NCT02787707
- Locations
- 🇮🇷
Department of Oncology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Khorasan Razavi, Iran, Islamic Republic of
Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers
- Conditions
- Experimental PainHyperalgesia
- Interventions
- Drug: Pulmodexane® 30mg
- First Posted Date
- 2015-11-04
- Last Posted Date
- 2016-04-01
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Target Recruit Count
- 20
- Registration Number
- NCT02596360
- Locations
- 🇫🇷
CHU Clermont-Ferrand, Clermont-Ferrand, France
Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)
- Conditions
- HealthyVascular StiffnessAging
- Interventions
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- University Hospital, Rouen
- Target Recruit Count
- 30
- Registration Number
- NCT02584439
- Locations
- 🇫🇷
Department of Pharmacology, Rouen university Hospital, Rouen, France
Anti-inflammatory Effect of Serum of Osteoarthritis Patients After Administration of the Oléogrape®SEED, an Extract of Grape and Olive
- Conditions
- Osteoarthritis
- Interventions
- Drug: Extract of grape and olive
- First Posted Date
- 2015-10-02
- Last Posted Date
- 2016-05-20
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT02566798
ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- First Posted Date
- 2014-12-29
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Belfast Health and Social Care Trust
- Target Recruit Count
- 49
- Registration Number
- NCT02326350
Glucosamine Periodontal Adjunctive Therapy
- Conditions
- Chronic Periodontitis
- Interventions
- First Posted Date
- 2014-08-12
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 40
- Registration Number
- NCT02214095
- Locations
- 🇪🇬
Ainshams University, Cairo, Egypt
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Drug: Placebo solutionDevice: RespimatDevice: Handihaler
- First Posted Date
- 2014-06-26
- Last Posted Date
- 2025-01-31
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 202
- Registration Number
- NCT02175342
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.